ZHUO JINCONG,METCALF BRIAN,XU MEIZHONG,HE CHUNHONG,ZHANG COLIN,QIAN DING-QUAN,BURNS DAVID M.,LI YUNLONG,YAO WENQING,ZHUO Jincong,METCALF Brian,XU Meizhong,HE Chunhong,ZHANG Colin,QIAN Ding-quan,BURNS David M.,LI
申请号:
SI200731149
公开号:
SI2099447T1
申请日:
2007.11.19
申请国别(地区):
SI
年份:
2013
代理人:
摘要:
The present invention is directed to imidazo[1,2-b][1,2,4]triazines and imidazo[1,2-a]pyrimidines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways.